Canagliflozin and renal outcomes in type 2 diabetes and nephropathy
- Submitting institution
-
Imperial College of Science, Technology and Medicine
- Unit of assessment
- 2 - Public Health, Health Services and Primary Care
- Output identifier
- 3043
- Type
- D - Journal article
- DOI
-
10.1056/NEJMoa1811744
- Title of journal
- New England Journal of Medicine
- Article number
- -
- First page
- 2295
- Volume
- 380
- Issue
- 24
- ISSN
- 0028-4793
- Open access status
- Compliant
- Month of publication
- April
- Year of publication
- 2019
- URL
-
-
- Supplementary information
-
-
- Request cross-referral to
- -
- Output has been delayed by COVID-19
- No
- COVID-19 affected output statement
- -
- Forensic science
- No
- Criminology
- No
- Interdisciplinary
- No
- Number of additional authors
-
23
- Research group(s)
-
B - Clinical trials and evaluation
- Citation count
- 1,064
- Proposed double-weighted
- No
- Reserve for an output with double weighting
- No
- Additional information
- -
- Author contribution statement
- The author made a substantial contribution to the conception and design of the study, the organisation of the conduct of the study, to carrying out the study, and to analysis and interpretation of study data. The author helped critique the output for important intellectual content.
- Non-English
- No
- English abstract
- -
